Follow this page and receive
notifications about new suppliers
Memantine API Manufacturers
compare suppliers & get competitive offers
Date | Seller | Exporter country | Buyer | Importer country | Product | Quantity (KG) | Price per KG | Latest transactions |
---|---|---|---|---|---|---|---|---|
27-Sep-2024 | (Hidden) | India | N/A | Taiwan (china) | ACTIVE PHA... | 45 | $ @36$-7! | Check all data |
27-Sep-2024 | (Hidden) | India | NOBEL ILAC... | Turkey | MEMANTINE ... | 40 | $ @36$-7! | |
26-Sep-2024 | (Hidden) | India | GLADPHARM ... | Ukraine | MEMANTINE ... | No data available | $ @36$-7! |
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Producer
Produced in:
Established in: 1972
MOQ: -
Employees: 1,000+
EU-GMP for APIs and CEP for certain APIs
Exporting to over 50 countries worldwide
Long-standing technological advantage in adamantane, quinuclidine and nitrofurane chemistry
+ 0
All certificates
Distributor
Produced in:
Established in: 2005
MOQ: -
Employees: 200+
Portfolio of over 2,000 APIs
Precise quality control
End-to-end global regulatory support
+ 0
All certificates
Producer
Established for 17 years and a leading enterprise in China's API industry
Mature technology and advanced production equipment
Quality assurance and fast delivery
+ 0
All certificates
Distributor
Produced in:
Established in: 2011
MOQ: 1 kg
Employees: 10+
Fast Response and Good Communication
Willingness To Start From Small
Flexible Payment Terms
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
Produced in:
Established in: 1944
MOQ: -
Employees: 4,000
14 international API plant sites
Portfolio of 350+ APIs
Teva is among the world’s largest generic drug/API manufacturers
+ 0
All certificates
Producer
+ 0
All certificates
Producer
Produced in:
Established in: 1984
MOQ: -
Employees: 21,650
Diverse portfolio of 180+APIs
1754+ DMF across global markets
1100+ patents filed, and more than 70 own patents granted
+ 0
All certificates
Producer
+ 0
All certificates
Distributor
Produced in:
Established in: 1963
MOQ: -
Employees: 800+
World’s 1st exclusive API distributor
Portfolio of 600+ APIs
>250 clients in Europe
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Memantine API 19982-08-2?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Memantine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Memantine
- Synonyms:
- Memantina , Memantine , Memantinum , Memantine Hydrochloride
- Cas Number:
- 19982-08-2
- DrugBank number:
- DB01043
- Unique Ingredient Identifier:
- W8O17SJF3T
About Memantine
Why are professionals looking for Memantine? Initially approved by the FDA in 2013, memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist used in the management of Alzheimer's Disease (AD). It is different from many other Alzheimer's Disease medications, as it works by a different mechanism than the cholinesterase enzyme inhibitors normally employed in the management of Alzheimer's disease Memantine blocks the effects of glutamate, a neurotransmitter in the brain that leads to neuronal excitability and excessive stimulation in Alzheimer's Disease In 2010, it was estimated that 36 million people worldwide live with Alzheimer's Disease. In 2013, this number increased to 44 million. Almost doubling every 20 years, the prevalence of Alzheimer's Disease is predicted to reach 66 million by 2030 and to 115 million by 2050.
Check who is selling Memantine in the overview above.
Memantine is a type of Nervous System Agents
Nervous System Agents are a crucial subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that target the intricate workings of the nervous system. These agents play a pivotal role in managing various neurological conditions and disorders by modulating the neurotransmitters and receptors involved in nerve signaling.
Nervous System Agents encompass a wide range of pharmaceutical APIs, including but not limited to antiepileptic drugs, antidepressants, antipsychotics, anxiolytics, and analgesics. These APIs work by interacting with specific molecular targets in the nervous system, such as neurotransmitter receptors or enzymes involved in neurotransmitter synthesis or degradation.
One notable class of Nervous System Agents is CGRP (Calcitonin Gene-Related Peptide) antagonists. CGRP is a neuropeptide involved in the transmission of pain signals in the central and peripheral nervous systems. CGRP antagonists act by blocking the CGRP receptors, thereby inhibiting the CGRP-mediated pain pathway.
CGRP antagonists have shown promising therapeutic potential in the management of migraine headaches. By selectively targeting CGRP receptors, these pharmaceutical APIs can effectively prevent or reduce the frequency and severity of migraines. They offer an alternative treatment option for patients who do not respond well to conventional migraine medications.
The development and utilization of Nervous System Agents, including CGRP antagonists, represent a significant advancement in the field of neuropharmacology. These APIs provide healthcare professionals with valuable tools to address various neurological disorders, ultimately improving patients' quality of life. Continued research and innovation in this subcategory are expected to lead to further breakthroughs in the treatment of nervous system-related conditions.
Memantine (Nervous System Agents), classified under Central Nervous System Agents
Central Nervous System (CNS) Agents are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that specifically target the central nervous system. The CNS encompasses the brain and spinal cord, playing a vital role in regulating and controlling various bodily functions, including cognition, movement, emotions, and sensory perception. These agents are designed to interact with specific receptors, enzymes, or ion channels within the CNS to modulate neural activity and restore normal functioning.
CNS agents comprise a diverse range of pharmaceutical APIs, including analgesics, anesthetics, antipsychotics, sedatives, hypnotics, anti-epileptics, and antidepressants. Each subcategory addresses distinct neurological disorders and conditions. For instance, analgesics alleviate pain by targeting receptors in the brain and spinal cord, while antipsychotics are employed to manage psychosis symptoms in mental illnesses such as schizophrenia.
The development of CNS agents involves rigorous research, molecular modeling, and extensive clinical trials to ensure safety, efficacy, and specific target engagement. Pharmaceutical companies invest significant resources in identifying novel drug targets, synthesizing new compounds, and optimizing their pharmacological properties. These agents undergo rigorous regulatory evaluations and must adhere to stringent quality standards and guidelines.
Given the prevalence of CNS disorders globally, the market demand for effective CNS agents is substantial. The development of innovative CNS APIs not only improves patient outcomes but also provides valuable commercial opportunities for pharmaceutical companies. Continued advancements in CNS agent research and development hold the promise of groundbreaking therapies that can improve the quality of life for individuals affected by neurological conditions.
Memantine manufacturers | traders | suppliers
We have 23 companies offering Memantine produced in 8 different countries.
Get in contact with the supplier of your choice:
- Olpha from Latvia, product country of origin Latvia
- LGM Pharma from United States, product country of origin World
- Xi'an ZB Biotech Co., Ltd from China, product country of origin China
- Shandong Octagon Chemicals Limited from China, product country of origin China
- Unichem Labs. from India, product country of origin India
- Industriale Chimica from Italy, product country of origin Unknown
- Sharon Bio-Medicine from India, product country of origin India
- Amsa S.P.A. from Italy, product country of origin Italy
- Teva API from Israel, product country of origin Unknown
- Tianjin Minxiang from China, product country of origin China
- Dr. Reddy's from India, product country of origin United Kingdom
- Hikal from India, product country of origin India
- TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
- DNP Fine Chemical Utsunomiya from Japan, product country of origin Japan
- Hetero Drugs from India, product country of origin India
- Sun Pharma from India, product country of origin India
- ZCL Chemicals from India, product country of origin India
- Piramal Healthcare from United Kingdom, product country of origin India
- Mylan from India, product country of origin India
- MSN Pharma from India, product country of origin India
- Procos from Italy, product country of origin Italy
- Emcure Pharma from India, product country of origin India
- Lupin from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.